2. J. Prettyman, "Subcutaneous or Intramuscular? Confronting a Parenteral Administration Dilemma," Medsurg. Nursing,
14 (2), 93–98 (2005).
3. H.C. Ansel, L.V. Allen, and N.G. Popovich, Pharmaceutical Dosage Forms and Drug Delivery Systems (Lippincott Williams & Wilkins, Philadelphia, PA, 8th ed., 2004).
4. A.L. Alcantara et al.,"Radiologic Study of Injection Drug Use Complications," Infect. Dis. Clin. North Am. 16 (3), 713–743 (2002).
5. P.D. Brown and J.R. Ebright, "Skin and Soft Tissue Infections in Injection Drug Users," Curr. Infect. Dis. Rep.
4 (5), 415–419 (2002).
6. S. Satyanarayana and A.D. Mathur, "Atypical Mycobacterial Injection Abscess," J. Indian Med. Assoc.
101 (1), 36–40 (2003).
7. S.C. DeWitt, Fundamental Concepts and Skills for Nursing (WB Saunders Company, Philadelphia, PA, 2001).
8. P.S. Bergeson, S.A. Singer, and A.M. Kaplan, "Intramuscular Injections in Children," Pediatrics 70 (6), 944–948 (1982).
9. A. Supersaxo, W.R. Hein, and H. Steffen, "Effect of Molecular Weight on the Lymphatic Absorption of Water-soluble Compounds
Following Subcutaneous Administration," Pharm. Res. 7 (2), 167–179 (1990).
10. Campath (alemtuzumab) Package Insert, Bayer Healthcare Pharmaceuticals, Wayne, NJ, Jan. 2007.
11. M.C. Hochberg et al., "Comparison of the Efficacy of the Tumor Necrosis Factor α-Blocking Agents Adalimumab, Etanercept,
and Infliximab When Added to Methotrexate in Patients with Active Rheumatoid Arthritis," Ann. Rheum. Dis. 62 (suppl 2), ii13–ii16 (2003).
12. E. Nemser and D. Azad, "Assessing the Impact of Differential Reimbursement of Medicare Pharmacy Benefits," Biotechnology Healthcare, Aug. 47–51 (2005).
13. T.D. Day, "The Permeability of Extracellular Connective Tissue and the Nature of the Interfibrillary Substance," J. Physiol.
117 (1), 1–8 (1952).
14. A.H. Paes, A. Bakker, and C.J. Soe-Agnie, "Impact of Dosage Frequency on Patient Compliance," Diabetes Care
20 (10), 1512–1517 (1997).
15. G.I Frost, "Recombinant Human Hyaluronidase (rHuPH20): An Enabling Platform for Subcutaneous and Fluid Administration," Expert Opin. Drug. Del. 4 (4), 427–440 (2007).
16. N. Verzijl et al., "Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products," J. Biol. Chem.
15 (50), 39027–39031 (2000).
17. U.B.G. Laurent, L.B. Dahl, and P.K. Reed, "Catabolism of Hyaluronan in Rabbit Skin Takes Place Locally in Lymph Nodes
and Liver," Exp. Physiol. 76 (5), 695–703 (1991).
|
